What’s Driving Cardinal Health Inc (CAH) Stock’s -0.19% Plunge Over the Past Month?
TD Cowen has recently raised Cardinal Health Inc (CAH) stock to Buy rating, as announced on Today, according to Finviz. Earlier, on January 7, 2025, Evercore ISI had raised the stock rating, setting a price target of $140. BofA Securities also raised Buy rating with a price target of $145. Additionally, Wells Fargo raised Equal […]
Cardinal Health Inc (CAH) Stock: A Deeper Look at Its True Potential
Wells Fargo has recently raised Cardinal Health Inc (CAH) stock to Equal Weight rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 4, 2024, Mizuho had resumed the stock to Outperform, setting a price target of $139. Leerink Partners also initiated Outperform rating with a price target of $125. Additionally, Argus […]
Cardinal Health Inc (CAH) Stock Rated Outperform by Mizuho
Mizuho has recently resumed Cardinal Health Inc (CAH) stock to Outperform rating, as announced on December 4, 2024, according to Finviz. Earlier, on February 26, 2024, Leerink Partners had initiated the stock to Outperform, setting a price target of $125. Argus also raised Buy rating. Additionally, Barclays initiated Overweight rating on January 3, 2024, with […]
Why Is Cardinal Health Inc (CAH) Stock Surpassing 4.56% from Its 50-Day SMA?
Mizuho has recently resumed Cardinal Health Inc (CAH) stock to Outperform rating, as announced on December 4, 2024, according to Finviz. Earlier, on February 26, 2024, Leerink Partners had initiated the stock to Outperform, setting a price target of $125. Argus also raised Buy rating. Additionally, Barclays initiated Overweight rating on January 3, 2024, with […]
Why Did Cardinal Health Inc (CAH) Stock Tumble -0.07% to $122.76?
Mizuho has recently resumed Cardinal Health Inc (CAH) stock to Outperform rating, as announced on December 4, 2024, according to Finviz. Earlier, on February 26, 2024, Leerink Partners had initiated the stock to Outperform, setting a price target of $125. Argus also raised Buy rating. Additionally, Barclays initiated Overweight rating on January 3, 2024, with […]
Why Did Cardinal Health Inc (CAH) Stock Rise 1.60% to $125.24?
Mizuho has recently resumed Cardinal Health Inc (CAH) stock to Outperform rating, as announced on Today, according to Finviz. Earlier, on February 26, 2024, Leerink Partners had initiated the stock to Outperform, setting a price target of $125. Argus also raised Buy rating. Additionally, Barclays initiated Overweight rating on January 3, 2024, with a target […]
Cardinal Health Inc (CAH) Stock Sees Market Value Hit $29.54 billion: What Are the Implications?
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
Cardinal Health Inc’s Stock Drama: Could This Be a Game-Changer for CAH Investors?
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
Uncover the Reason: Why Cardinal Health Inc (CAH) Stock Is Trading 30.70% Above Its 52-Week Low?
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
Cardinal Health Inc (CAH) Stock: Analyzing Its Quiet Power
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
